Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Manufacturing & engineering

IMI to expand into pharmaceutical sector with US acquisition

PBM enjoys strong distributor and representative relationships - particularly within its main US markets.

Metal basher IMI PLC (LON:IMI) is to acquire industrial valves and flow control products producer PBM Inc for an enterprise value of US$85mln (£70.3mln).

PBM, which in 2018 generated underlying earnings (adjusted EBITDA) of US$6.8mln (£5.6mln) on revenues of US$35.6mln (£29.4mln), will be subsumed into IMI's Critical Engineering division.

IMI said the acquisition extends IMI Critical Engineering's market presence into new, growing segments - including pharmaceutical/biotechnology.

The group added that the acquisition will boost IMI's margins and earnings.

“The business has fantastic products, a market-leading position and an excellent reputation - particularly in markets that are new to IMI,” said Jackie Hu, the divisional managing director of IMI Critical Engineering.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK